Journals / Ahi Evran Tıp Dergisi / 2021 / Cilt: 5 Sayı: 3

Our Clinical and Surgical Treatment Results in Familial Adenomatous Polyposis Coli Patients

Familyal Adenomatöz Polipozis Koli’li hastalarda Klinik ve Cerrahi Tedavi Sonuçlarımız

Pages
184–190
Publication Date
2021-12-22
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The type of surgery to be performed should be decided according to the age of the patient, the prevalence of polyp and compliance with follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Familial adenomatous polyposis coli (FAP) is characterized by multiple adenomatous polyps in the colorectal region.
📊
Key Findings & Data:In this study, it was aimed to present the results of patients who underwent surgical treatment with the diagnosis of FAP and the experiences of our clinic to theliterature.Materials and Methods: The files of patients who underwent surgery for FAP between 2011 and 2020 in our center were retrospectively reviewed.
💡
Conclusion & Impact:The type of surgery to be performed should be decided according to the age of the patient, the prevalence of polyp and compliance with follow-up.
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Familyal Adenomatöz Polipozis · kanser · kolektomi

Abstract

Purpose: Familial adenomatous polyposis coli (FAP) is characterized by multiple adenomatous polyps in the colorectal region. Surgical treatment is the most decisive factor in FAP patients, as the risk of colorectal cancer is inevitable. In this study, it was aimed to present the results of patients who underwent surgical treatment with the diagnosis of FAP and the experiences of our clinic to theliterature.Materials and Methods: The files of patients who underwent surgery for FAP between 2011 and 2020 in our center were retrospectively reviewed. Patients with multiple data deficiencies were excluded. 30 patients were included in the study. The findings of the patients were recorded.Results: 13 (43%) of the patients were male, 17 (57%) were female. Total proctocolectomy (TPK) was performed in 17 (57%) of the patients, and TK was performed in 13 (43%) of them. 15 of the patients' colonoscopies included suspicion of malignancy. Eight of the colonoscopic biopsies of these patients were adenocarcinoma. Specimen pathology was adenocarcinoma in 20 (67%) of the patients.Complications were seen in 10 (33%) of the patients and mortality was seen in 1. Complications were more common in patients with TPK (60%).Conclusion: Although FAP mostly involves the colon, it may involve the upper gastro intestinal system. Although surgery is still the most important step of the treatment, the complication rates are substantial. The type of surgery to be performed should be decided according to the age of the patient, the prevalence of polyp and compliance with follow-up.

Özet

Amaç: Familyal adenomatöz polipozis koli (FAP) kolorektal bölgede çok sayıda adenomatöz polip ile karakterizedir. FAP hastalarında kolorektal kanser riski kaçınılmaz olduğundan cerrahi tedavi en belirleyici unsurdur. Bu çalışmada FAP tanısı ile cerrahi tedavi uygulanan hastaların sonuçlarının ve kliniğimizin deneyimlerinin literatüre sunulması amaçlanmıştır.Araçlar ve Yöntem: Merkezimizde 2011-2020 tarihleri arasında FAP nedeniyle cerrahi uygulanan hastaların dosyaları geriye dönük olarak incelendi. Çoklu veri eksikliği olan hastalar çalışma dışı bırakıldı. 30 hasta çalışmaya alındı. Hastaların bulguları kaydedildi.Bulgular: Hastaların 13’ü (%43) erkek, 17’si (%57) kadındı. Hastaların 17’sine (%57) total proktokolektomi (TPK), 13’üne (%43) TK yapıldı. Hastaların kolonoskopilerinin 15’i malignite şüphesi içeriyordu. Bu hastaların kolonoskopik biyopsilerin 8’i adenokanserdi. Hastaların 20’sinde (%67) spesmen patolojisi adenokanserdi. Hastaların 10’unda (%33) komplikasyon ve 1’inde mortalite görüldü. Komplikasyonlar TPK (%60) yapılan hastalarda daha çoktu.Sonuç: FAP daha çok kolonu ilgilendirse de üst gastrointestinal sistemi de tutabilmektedir. Cerrahi, halen tedavinin en önemli basamağını oluştursa da komplikasyon oranları azımsanmayacak düzeylerdedir. Yapılacak cerrahinin türüne hastanın yaşı, polip yaygınlığı ve takiplere olan uyum durumuna göre karar verilmelidir.

🔖

Cite This Article

GÜNDOĞDU, R., YABANOĞLU, H., ERKAN, S., KUŞ, M. (2021). Our Clinical and Surgical Treatment Results in Familial Adenomatous Polyposis Coli Patients. Ahi Evran Tıp Dergisi, Cilt: 5 Sayı: 3, 184–190. https://ajindex.com/articles/898856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bhurwal A, Prochilo G, Patel AV. Familial adenomatous polyposis. Am J Med Sci. 2020;359(6):392-393
  2. Nielsen M, Hes FJ, Nagengast FM, et. al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet. 2007;71(5):427-433
  3. Knudsen AL, Bülow S, Tomlinson I, Möslein G, Heinimann K, Christensen IJ. Attenuated familial denomatous polyposis: resultsfrom an internationa lcollaborative study. Colorectal Dis. 2010;12(10):243–249
  4. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J RareDis. 2009;4(1):22
  5. Aliosmanoğlu İ, Gül M, Hakseven M.ve ark. Familyal adenomatöz polipozis nedeniyle ameliyat ettiğimiz 24 hastanın analizi. Kolon Rektum Hast. Derg. 2013;23(1):38-43
  6. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1990;33(8):639-642
  7. Laurent S, Franchimont D, Coppens J. P. et. al. Familial adenomatous polyposis: clinical presentation, detection and surveillance. Acta gastroenterol. 2011;74(3):415-420
  8. Aihara H, Kumar N, Thompson CC. Diagnosis, surveillance, and reatment strategies for familial adenomatous polyposis: rationale and update. Eur J Gastroenterol Hepatol. 2014;26(3):255-262
  9. Campos FG. Surgical treatment of familial adenomatous polyposis: Dilemmas and currentre commendations. World J Gastroenterol. 2014;20(44):16620-16629
  10. Dolan S. Familial adenomatous polyposis: development, presentation, and treatment strategies. Clin J Oncol Nurs. 2019;23(2):135-138
  11. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, WuTT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-cateningene. Am J Pathol. 2001;158(3):1005-1010
  12. Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut. 200;50(5):636-641
  13. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;2(8666):783-785
  14. Sherman J, Greenstein AJ, Greenstein AJ. Ileal j pouch complications and surgical solutions: a review. Inflamm Bowel Dis. 2014;20(9):1678-1685
  15. Aziz O, Athanasiou T, Fazio VW, et al. Meta-analysis of observational studies of ileorectal versus ilealpouch-anal anastomosis for familial adenomatous polyposis. Br J Surg.